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Urine Creatinine Excretion in HIV 
and Non-HIV Subjects
Ernest Ndukaife Anyabolu
Abstract
This study assessed urine creatinine in spot and 24-hour samples in HIV and 
non-HIV population. We categorized dilute urine as a 24-hour urine creatinine 
<300 mg, concentrated urine as a 24-hour urine creatinine >3000 mg, and nor-
mal urine as a 24-hour urine creatinine 300–3000 mg. Association of variables 
with creatinine was evaluated. In HIV subjects, the mean spot urine creatinine 
was 137.21 ± 98.47 mg/dl and a 24-hour urine creatinine was 1507 ± 781 mg.  
The prevalence of dilute urine was 0.5%, normal urine 93.1%, and concentrated 
urine 6.4%. 20-hour urine creatinine was associated with serum LDL, and 
HDL. Concentrated urine was correlated with a 24-hour urine osmolality (r = 
0.95), serum HDL (r = −0.73), CD4 cells count (r = −0.71), and BMI (r = 0.74). 
Dyslipidemia was common in HIV subjects with concentrated urine. In non-HIV 
subjects, the mean spot urine creatinine was 148 ± 167 mg/dl and the 24-hour 
urine creatinine was 1203 ± 316 mg. The 24-hour urine creatinine was within 
the normal range. The spot urine creatinine significantly correlated with BMI, 
spot urine protein, spot urine osmolality, 24-hour urine protein, 24-hour urine 
creatinine, serum creatinine, serum cholesterol, and serum LDL. Conversely, 
the 24-hour urine creatinine significantly correlated with 24-hour urine volume, 
serum creatinine, and serum cholesterol. The spot urine protein and 24-hour 
urine protein were predictors of spot urine creatinine. Serum creatinine was 
a predictor of 24-hour urine creatinine. Proteinuric renal abnormalities were 
common.
Keywords: HIV, urine creatinine, spot urine creatinine, 24-hour urine creatinine, 
CD4 cell count, concentrated urine, dilute urine, abnormal weight, dyslipidemia, 
proteinuria
1. Introduction
1.1 Impact of HIV
Human immunodeficiency virus infection is a world healthcare burden with 
sub-Saharan Africa as a geographic area accounting for about 70% of HIV-infected 
persons [1]. In Nigeria the prevalence of HIV is 3.7% [1]. HIV infection directly or 
indirectly affects most organs of the body [2]. In like manner, tons of physiological 
responses are also altered by HIV disease process [3–5].
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1.2 Factors which may influence creatinine
Creatinine is produced by the muscles, degraded within the liver, and efficiently 
excreted by the kidney at a rate that is not only constant but is additionally modu-
lated by weight, gender, and age [6].
Many environmental, physiologic, and disease conditions may impact on daily 
urine creatinine excretion. Excretion of creatinine is further altered by exogenous 
substances such as cocaine and heavy metals which include arsenic and cadmium 
seen within the bioenvironment related to environmental pollution. Others 
include meat consumption and medications such as cimetidine and trimethoprim. 
Consequently, urine creatinine is employed in monitoring bioenvironmental 
pollutants and substance use [7–9].
1.3 Variability of daily urine creatinine
There is high variability of the values of daily urine creatinine excretion in 
normal healthy state [10]. Impaired renal function usually results in poor renal 
secretion of creatinine in urine; urine creatinine decreases as renal function impair-
ment increases [11].
1.4 Identified factors of high and low 24-hour urine creatinine
Studies have identified some associated factors of high 24-hour urine creatinine 
or concentrated urine. They include age, sex, race, body mass index, hyperten-
sion, water intake, and blood osmolality [12]. At the other pole, low 24-hour urine 
creatinine or dilute urine was reported to be associated with glomerular filtration 
rate, an older age, diabetes, and lower levels of body mass index, proteinuria, and 
protein intake [11]. Another important use of urine creatinine is for evaluating the 
completeness of 24-hour urine sample collection [13].
1.5  A necessity for routine assessment of urine creatinine in HIV and non-HIV 
subjects
Studies are sparse on urine creatinine in HIV and non-HIV subjects originating 
from Nigeria. We have, therefore, launched to evaluate urine creatinine and factors 
which influence low and high urine creatinine in these groups of subjects.
2. Methods
2.1 Study location and population
This was a cross-sectional study, comprising 375 HIV-positive subjects and 
136 subjects recruited from an HIV clinic and also the general outpatient clinic, 
respectively, of the Federal Medical Centre, Owerri, Nigeria. The study was 
disbursed and carried out between April and August 2011. The standards for inclu-
sion were HIV-positive status for the HIV subjects and HIV-negative status for the 
non-HIV participants. For both groups of subjects, another criterion was age range 
of 16–65 years. The themes excluded from the study were people who had adrenal, 
pituitary, and renal diseases, terminal illness, and pregnancy. For the non-HIV 
subjects, the inclusion criteria were similar, but those with HIV-positive status 
were excluded.
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2.2 Ethics approval
The study was approved by the ethics research committee of the hospital. Its 
approval reference number was FMC/HCS/VOL II and was dated 16 March, 2011. 
Informed written consent was obtained from all the themes participated within 
the study.
2.3 Variables, data collection, and sample analyses
With the help of a questionnaire, demographic, anthropometric, and other rel-
evant data were obtained from the themes. The purpose of the study was explained 
to the themes. The age, gender, place of origin, and domicile were obtained. Height 
was measured and recorded in meter (m). Weight was measured employing a 
weighing scale. Body mass index was taken as the ratio of weight/height2 (kg/m2).
The study participants were clearly instructed on the way to collect 24-hour 
urine sample. At the conclusion of the 24-hour urine sample collection, blood 
samples, and daytime random spot urine samples were collected. Spot urine 
creatinine, spot urine osmolality, and spot urine protein from the random spot 
urine samples were performed. Also from the 24-hour urine samples collected, 
24-hour urine protein, 24-hour urine creatinine, and 24-hour urine osmolality 
were performed. Serum creatinine was performed on the blood samples collected. 
Freezing point depression assay was used to determine osmolality, protein by pho-
tometric method, and creatinine by modified Jaffe’s method. Creatinine clearance 
and spot urine creatinine/osmolality ratio were calculated. HIV screening and 
confirmatory tests, fasting serum lipid profile, CD4 cell count, and hemoglobin 
were performed.
2.4 Potential risk variables analyzed
The potential associated factors of dilute and concentrated urine evaluated were 
CD4 cells, spot urine protein, spot urine osmolality, 24-hour urine osmolality, 24-hour 
urine protein, spot urine creatinine/osmolality ratio, creatinine clearance, serum 
cholesterol, serum low-density lipoprotein cholesterol, serum triglyceride, and serum 
high-density lipoprotein cholesterol.
2.5 Statistical analyses
The data were analyzed using SPSS version 17.0 (SPSS Inc. Chicago, IL, USA). The 
distribution and characterization of clinical and laboratory variables within the study 
participants with different levels of 24-hour urine creatinine were analyzed using 
cross-tabulation, whereas statistical significance of association of these variables 
with 24-hour urine creatinine levels was evaluated using Student’s t-test. Correlation 
statistics were used to determine the association of those variables with concentrated 
urine on the one hand and with dilute urine on the other hand. The strength of vari-
ables to predict dilute urine and concentrated urine was determined using multivari-
ate linear regression analyses. P < 0.05 was taken as statistically significant.
2.6 Definition of terms
Normal urine creatinine: 24-hour urine creatinine 300–3000 mg. Low urine 
creatinine or dilute urine: 24-hour urine creatinine <300 mg. High urine creatinine 
or concentrated urine: 24-hour urine creatinine >3000 mg.
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3. Results
3.1 Results in HIV patients
3.1.1 Age, spot urine, and 24-hour urine creatinine in HIV patients
Out of the 393 participants studied, 18 were excluded due to errors from 
incomplete sample collection. Their mean age was 39 ± 11 years. For all the HIV 
participants, the mean spot urine creatinine was 137.21 ± 98.47 (mg/dl), minimum 
value 13.3 mg/dl, maximum value 533.3 mg/dl, and range 520.0 mg/dl. The mean 
24-hour urine creatinine was 1507 ± 781 mg, minimum value 206 mg, maximum 
value 4849 mg, with a range of 4643 mg (Table 1).
3.1.2 Prevalence of dilute and concentrated urine and factors of 24-hour urine
Two (0.5%) of the HIV subjects have 24-hour urine creatinine <300 mg, 349 
(93.1%) have 300–3000 mg, and 24 (6.4%) have >3000 mg. Serum low-density 
lipoprotein cholesterol was significantly associated with 24-hour (p = 0.001) in 
these HIV subjects. Two subjects have 24-hour urine creatinine <300 mg, and both 
of them have borderline serum low-density lipoprotein cholesterol. Twenty-four 
subjects have high urine creatinine, and all of them have desirable serum low-
density lipoprotein cholesterol (Table 2).
3.1.3 Dilute urine, concentrated urine, and serum HDL in HIV patients
There was a significant association between serum high-density lipoprotein 
cholesterol and 24-hour urine creatinine, p = 0.028, in the HIV subjects. Two subjects 
Variables (mean ± SD) HIV subjects
Body mass index (kg/m2) 26.2 ± 5.4
Hemoglobin (g/dl) 11.2 ± 1.8
CD4 cells/ml (median) 391
SUOsm (mOsm/kgH2O) 464 ± 271
Spot urine protein (mg/dl) 11.89 ± 19.13
Spot urine creatinine (mg/dl) 137.21 ± 98.47
24-hour urine protein (g) 0.187 ± 0.290
24-hour urine creatinine (mg) 1507 ± 781
24HUOsm (mOsm/kgH2O) 564 ± 501
SUCOR (mg/dl/mOsm/kgH2O) 0.422 ± 0.486
Cholesterol (mmol/l) 4.26 ± 0.90
Triglyceride (mmol/l) 1.23 ± 0.37
HDL (mmol/l) 1.18 ± 0.39
LDL (mmol/l) 2.05 ± 0.58
Creatinine clearance (mls/min) 91.42 ± 22.98
SD, standard deviation; SUOsm, spot urine osmolality; 24HUOsm, 24-hour urine osmolality; SUCOR, spot urine 
creatinine/osmolality ratio; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.
Table 1. 
Variables in HIV patients.
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Variables 24-hour urine creatinine levels (no (%)) Chi-
square
Likelihood 
ratio
P 
value
<300 mg 300–750 mg >750 mg
BMI (kg/m2) 
< 18.5
0 (0.0%) 22 (91.7%) 2 (8.3%) 8.702 0.143 0.191
18.5–24.9 0 (0.0%) 124 (96.9%) 4 (3.1%)
25.0–29.9 2 (1.4%) 128 (88.9%) 14 
(9.7%)
≥30 0 (0.0%) 75 (94.9%) 4 (5.1%)
CD4 cell count 
<200
0 (0.0%) 41 (97.1%) 4 (8.9%) 0.781 0.614 0.677
≥200 2 (0.6%) 307 (93.3%) 20 
(6.1%)
Hb (g/dl) ≥12.0 2 (1.6%) 108 (88.5%) 12 
(9.8%)
9.644 0.107 0.140
10.0–11.9 0 (0.0%) 163 (96.4%) 6 (3.6%)
7.0–9.9 0 (0.0%) 72 (92.3%) 6 (7.7%)
<7.0 0 (0.0%) 6 (100.0%) 0 
(0.0%)
ClCr  
(mls/min) ≥ 90 
mls/min
0 (0.0%) 183 (92.0%) 16 
(8.0%)
5.229 0.204 0.265
60–89 2 (1.4%) 135 (94.4%) 6 (4.2%)
30–59 0 (0.0%) 31 (93.9%) 2 (6.1%)
24 HUP <0.300 g 2 (0.6%) 301 (93.8%) 18 
(5.6%)
8.018 0.178 0.237
≥0.300 g 0 (0.0%) 48 (88.9%) 6 
(11.1%)
FSLP (mmol/l)
CholT Des (<5.2) 2 (0.6%) 308 (92.5%) 23 
(6.9%)
1.618 0.806 0.659
BorderL (5.2–6.2) 0 (0.0%) 35 (97.2%) 1 (2.8%)
High (>6.2) 0 (0.0%) 6 (100.0%) 0 
(0.0%)
LDL Des (<2.6) 0 (0.0%) 284 (92.2%) 24 
(7.8%)
14.609 <0.001 0.001
BorderL (2.6–4.1) 2 (3.0%) 64 (97.0%) 0 
(0.0%)
HDL Low (<1) 2 (1.5%) 124 (95.4%) 4 (3.1%) 7.317 0.016 0.028
High (≥1) 0 (0.0%) 225 (91.8%) 20 
(8.2%)
TG Des (<1.7) 2 (0.6%) 311 (92.3%) 24 
(7.1%)
3.150 0.449 0.790
BorderL (1.7–2.2) 0 (0.0%) 29 (100.0%) 0 
(0.0%)
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have 24-hour urine creatinine <300 mg, and both have desirable serum high-
density lipoprotein cholesterol <1 mg/dl. Twenty-four subjects have 24-hour urine 
creatinine >3000 mg. Out of this number, 83.3% have high serum high-density 
lipoprotein cholesterol, whereas 16.7% have desirable serum high-density lipopro-
tein cholesterol. This showed that the prevalence of high urine creatinine increased 
as serum high-density lipoprotein cholesterol increased (Table 2).
3.1.4  Dissociation and association between daily urine creatinine excretion and 
variables in HIV patients
There was no significant association between 24-hour urine creatinine and 
body mass index, p = 0.191; serum total cholesterol, p = 0.659; creatinine clear-
ance, p = 0.265; 24-hour urine protein, p = 0.237; CD4 cell count, p = 0.677; 
serum triglyceride, p = 0.790; and hemoglobin, p = 0.140 in the HIV subjects 
(Table 2). Significant correlation was obtained between 24-hour urine creatinine 
and spot urine creatinine (p = 0.19), 24-hour urine volume (p = 0.004), spot urine 
creatinine/osmolality ratio (<0.001), serum low-density lipoprotein cholesterol 
(p = 0.31), creatinine clearance (p < 0.001), and serum creatinine (<0.001) in the 
treatment-naïve HIV subjects. Hemoglobin, spot urine protein, spot urine osmolal-
ity, 24-hour urine protein, 24-hour urine osmolality, serum cholesterol, serum 
high-density lipoprotein cholesterol, and serum triglyceride did not have significant 
correlation with 24-hour urine creatinine (Table 3).
3.1.5 Correlates of daily urine creatinine excretion in HIV patients
There was a very strong correlation between 24-hour urine creatinine 
>3000 mg and 24-hour urine osmolality (r = 0.95), body mass index, (r = 0.74), 
CD4 cell count, (r = −0.71), and serum high-density lipoprotein cholesterol 
(r = −0.73) in the HIV subjects. However, there was a moderate correlation 
between 24-hour urine creatinine and 24-hour urine volume (r = 0.58) and 
hemoglobin (r = −0.43). Conversely, there was a poor correlation between spot 
urine creatinine and body mass index (r = 0.131, p = 0.009)), spot urine protein 
(r = 0.183, p = <0.001), spot urine osmolality (r = 0.288, p = <0.001), 24-hour 
urine volume (r = −0.111, p = 0.032), and creatinine clearance (r = 0.108, 
p = 0.036) (Table 4).
3.1.6 Predictors of concentrated urine in HIV patients
Multivariate linear regression of 24-hour urine creatinine >3000 mg with its 
potential risk factors was voided as the colinearity variance was skewed due to the 
small subpopulation (24) that have 24-hour urine creatinine >3000 mg.
Variables 24-hour urine creatinine levels (no (%)) Chi-
square
Likelihood 
ratio
P 
value
<300 mg 300–750 mg >750 mg
High (>2.2) 0 (0.0%) 8 (100.0%) 0 
(0.0%)
LHR, likelihood ratio; BMI, body mass index; Hb, hemoglobin; ClCr, creatinine clearance; 24HUP, 24-hour urine 
protein; FSLP, fasting serum lipid profile; CholT, total cholesterol; Des, desirable; BorderL, borderline; LDL,  
low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; TG, triglyceride.
Table 2. 
Distribution and characterization of variables at different levels of 24-hour urine creatinine in HIV-positive 
patients (n = 375).
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Variables Correlation coefficient (r) P value
Body mass index −0.036 0.470
Hemoglobin (g/dl) 0.075 0.117
Spot urine protein 0.044 0.538
Spot urine creatinine 0.129 0.019
Spot urine osmolality 0.107 0.058
24-hour urine protein 0.035 0.625
24-hour urine osmolality 0.063 0.167
24-hour urine volume 0.143 0.004
SUCOR 0.288 <0.001
Serum creatinine 0.290 <0.001
Serum cholesterol (total) 0.074 0.242
Serum Triglyceride −0.075 0.189
Serum HDL 0.029 0.542
Serum LDL −0.109 0.031
Creatinine clearance 0.367 <0.001
SUCOR, spot urine creatinine osmolality ratio; HDL, high-density lipoprotein cholesterol; LDL, low-density 
lipoprotein cholesterol.
Table 3. 
Correlation of 24HUCr with variables in HIV patients (n = 375).
Variables Correlation coefficient (r) P value
Body mass index 0.744 <0.001
Hb (g/dl) −0.427 <0.001
Spot urine protein 0.397 <0.001
Spot urine creatinine 0.371 <0.001
Spot urine osmolality −0.549 <0.001
24-hour urine protein −0.109 0.001
24-hour urine osmolality 0.952 <0.001
24-hour urine volume 0.578 <0.001
Serum creatinine −0.198 <0.001
Serum cholesterol (total) 0.215 <0.001
Serum triglyceride 0.001 0.925
Serum HDL −0.729 <0.001
Serum LDL 0.289 <0.001
Hemoglobin −0.427 <0.001
SUCOR, spot urine creatinine osmolality ratio; HDL, high-density lipoprotein cholesterol; LDL, low-density 
lipoprotein cholesterol.
Table 4. 
Correlation of 24HUCr > 3000 mg with variables in HIV patients (n = 24).
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3.2 Results in non-HIV subjects
3.2.1 Values of spot urine and 24-hour urine creatinine in non-HIV subjects
Out of the 136 non-HIV subjects enrolled in this study, females constituted 
72.1% and males 27.9%. Their mean age was 39 ± 12 years. They all have complete 
data or sample collection, and there was no attrition. The value of the mean 
spot urine creatinine was 148 ± 167, minimum value 14.7 mg/dl, and maximum 
value 746.7 mg/dl with a range of 732.0 mg/dl. Further, the value of the mean 
24-hour urine creatinine was 1203 ± 316, minimum value 651.0 mg, maximum 
value 2320 mg, and range 1669.0 mg. The mean values of all other variables are 
depicted in Table 5.
For all the subjects the mean 23-hour urine creatinine was in the normal range 
(300–3000 mg). The potential risk factors for concentrated or dilute urine were 
voided and could not be distributed or characterized.
3.2.2 Correlates of spot urine creatinine
There was a significant correlation between spot urine creatinine and body 
mass index (r = 0.225, p = 0.009), spot urine protein (r = 0.292, p = 0.001), spot 
urine osmolality (r = 0.223, p = 0.009), serum low-density lipoprotein cholesterol 
(r = 0.282, p = 0.001), 24-hour urine protein (r = −0.187, p = 0.030), 24-hour urine 
creatinine (r = −0.178, p = 0.038), serum creatinine (r = −0.212, p = 0.013), as well 
as serum cholesterol (r = 0.246, p = 0.004). In contrast, spot urine creatinine has 
no significant correlation with hemoglobin, 24-hour urine volume, 24-hour urine 
Variables (mean ± SD) Subjects
Body mass index (kg/m2) 25.5 ± 6.5
Hemoglobin (g/dl) 12.9 ± 1.6
Serum creatinine (mg/dl) 0.88 ± 0.19
SUOsm (mOsm/kgH2O) 334 ± 204
Spot urine protein (mg/dl) 7 ± 18
Spot urine creatinine (mg/dl) 148 ± 167
24-hour urine volume (ml) 1874 ± 681
24-hour urine protein (g) 0.095 ± 0.087
24-hour urine creatinine (mg) 1203 ± 316
24HUOsm (mOsm/kgH2O) 160 ± 133
Cholesterol (mmol/l) 3.8 ± 1.2
Triglyceride (mmol/l) 1.2 ± 0.4
HDL (mmol/l) 1.2 ± 0.3
LDL (mmol/l) 2.3 ± 1.0
Creatinine clearance (mls/min) 93.0 ± 41.2
SD, standard deviation; SUOsm, spot urine osmolality; 24UOsm, 24-hour urine osmolality; HDL, high-density 
lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.
Table 5. 
Variables in non-HIV subjects (n = 136).
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osmolality, serum triglyceride, serum high-density lipoprotein cholesterol, as well 
as creatinine clearance (Table 6).
3.2.3 Correlates of 24-hour urine creatinine
Twenty-four-hour urine creatinine significantly correlated with 24-hour urine 
volume (r = 0.213, p = 0.013), serum creatinine (r = 0.741, p < 0.001), and spot 
urine creatinine (r = −0.178, p < 0.001). On the contrary, 24-hour urine creatinine 
did not significantly correlate with body mass index, hemoglobin, spot urine pro-
tein, spot urine osmolality, 24-hour urine protein, 24-hour urine osmolality, serum 
cholesterol, serum triglyceride, serum high-density lipoprotein cholesterol, as well 
as serum low-density lipoprotein cholesterol (Table 7).
Twenty-four-hour urine protein significantly correlated with 24-hour urine 
volume (r = 0.213, p = 0.013), serum creatinine (r = 0.741, p < 0.001), and spot 
urine creatinine (r = −0.178, p < 0.001).
3.2.4 Predictors of spot urine creatinine
The variables that predicted spot urine creatinine were spot urine protein 
(p < 0.001) and 24-hour urine protein (p = 0.021), whereas body mass index, 
serum creatinine, spot urine osmolality, 24-hour urine creatinine, serum choles-
terol, and serum low-density lipoprotein cholesterol did not (Table 8).
3.2.5 Predictor of 24-hour urine creatinine in non-HIV subjects
Only one variable predicted 24-hour urine creatinine—serum creatinine 
(p < 0.001)—whereas spot urine creatinine and 24-hour urine volume did  
not (Table 9).
Variables Correlation coefficient(r) P value
Body mass index 0.225 0.009
Hemoglobin 0.024 0.782
Spot urine protein 0.292 0.001
Spot urine osmolality 0.223 0.009
24-hour urine protein −0.187 0.030
24-hour urine creatinine −0.178 0.038
24-hour urine volume −0.097 0.259
24HUOsm −0.165 0.055
Serum creatinine −0.212 0.013
Serum cholesterol (total) 0.246 0.004
Serum Triglyceride 0.157 0.067
Serum HDL 0.137 0.112
Serum LDL 0.282 0.001
Creatinine clearance 0.024 0.782
HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; 24HUOsm, 24-hour urine 
osmolality.
Table 6. 
Correlation of spot urine creatinine with variables in non-HIV subjects (n = 136).
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Body mass index 0.056 0.520
Hemoglobin 0.046 0.593
Spot urine protein −0.083 0.337
Spot urine osmolality −0.091 0.294
Spot urine creatinine −0.178 0.038
24-hour urine protein −0.027 0.753
24-hour urine volume 0.213 0.013
24-hour urine osmolality 0.106 0.220
Serum creatinine 0.741 <0.001
Serum cholesterol (total) −0.032 0.708
Serum triglyceride −0.008 0.925
Serum HDL 0.038 0.657
Serum LDL −0.092 0.286
Creatinine clearance 0.634 <0.001
HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.
Table 7. 
Correlation of 24-hour urine creatinine with variables in non-HIV subjects.
Variables Beta T P value 95% CI
Body mass index 0.107 1.160 0.248 −1.964–7.523
Serum creatinine −0.200 −1.729 0.086 −282.537–23.785
Spot urine protein 0.312 3.760 <0.001 1.350–4.346
Spot urine osmolality 0.100 1.318 0.190 −0.045–0.225
24-hour urine protein −0.184 −2.331 0.021 −53.513 0–0.354
24-hour urine creatinine 0.026 0.228 0.820 −105.945–133.584
Serum cholesterol −0.136 −0.632 0.528 −1.952–1.007
Serum LDL 0.375 1.804 0.074 −0.148–3.199
CI, confidence interval; LDL, low-density lipoprotein cholesterol.
Table 8. 
Multivariate linear regression of variables with spot urine creatinine in non-HIV subjects (n = 136).
Variables Beta T P value 95% CI
Serum creatinine 0.723 26,353 <0.001 −1.065–0.814
Spot urine creatinine −0.003 −0.097 0.923 0.000–0.000
24-hour urine volume −0.038 −1.389 0.167 0.011–0.013
CI, confidence interval.
Table 9. 
Multivariate linear regression of variables with 24-hour urine creatinine in non-HIV subjects (n = 136).
11
Urine Creatinine Excretion in HIV and Non-HIV Subjects
DOI: http://dx.doi.org/10.5772/intechopen.91416
4. Discussion
4.1 Discussion in HIV patients
4.1.1 Prevalence of dilute urine in HIV patients
This study noted the prevalence of dilute urine or low urine creatinine of 0.5% 
and concentrated urine or high urine creatinine of 6.4% in HIV patients. It showed 
an association between high urine creatinine and serum low-density lipoprotein cho-
lesterol, p = 0.001, as well as serum high-density lipoprotein cholesterol, p = 0.028. 
It further showed that high urine creatinine very strongly correlated with 24-hour 
urine osmolality (r = 0.95), body mass index (r = 0.74), CD4 cell count (r = −0.71), 
and serum high-density lipoprotein cholesterol (r = −0.73). In this study the preva-
lence of low urine creatinine was 0.5%. This is in disagreement with 8.1% docu-
mented by Barr et al. [14]. In the same vein, the observed 6.4% prevalence of high 
urine creatinine in this study was a bit higher than the 3.1% reported by Barr et al. 
[14] in the same study previously mentioned. Differences in study design perhaps 
might explain the observed difference in the prevalence. Whereas the subjects in this 
group of our study participants were HIV patients in Nigeria, their study partici-
pants were non-HIV from a US general population. In Romania, studies reported 
high chronic kidney disease prevalence in HIV patients who were on variable antiret-
roviral therapy duration [15–17]. These Romanian studies evaluated kidney disease 
using MDRD equation, a formula that incorporated serum creatinine in its utility. 
Glaringly, however, their study failed to analyze daily urine creatinine excretion.
4.1.2 Concentrated urine associated with serum LDL and HDL in HIV patients
This study demonstrated a significant association between high urine 
creatinine and serum low-density lipoprotein cholesterol as well as serum high-
density lipoprotein cholesterol. Literature was sparse on the impact of high urine 
creatinine excretion on serum low-density lipoprotein cholesterol or serum 
high-density lipoprotein cholesterol. Nonetheless, in chronic kidney disease, low 
serum low-density lipoprotein cholesterol and low serum high-density lipoprotein 
cholesterol are characteristic components of dyslipidemia. Lipid synthesis by the 
liver is thought to be induced by proteinuria in kidney disease. Triglyceride-rich 
apolipoprotein B (apoB) containing complex lipoproteins, mark these syntheses. 
They have profound atherogenic potential which inadvertently will impact nega-
tively on the kidney and subsequently affect urine creatinine excretion [18–20].
4.1.3 Concentrated urine associated with 24-hour urine osmolality in HIV patients
This study showed that there was very strong correlation between high urine 
creatinine and 24-hour urine osmolality (r = 0.95). A similar observation was 
reported in a study that assessed the utility of urine creatinine and urine osmolal-
ity in determining dilute or concentrated urine and therefore the factors that 
influenced these. That study observed that the quantum of associations depicted 
as a fraction in change was profoundly stronger with urine creatinine than urine 
osmolality. The report noted that urine osmolality, compared to urine creatinine, 
was influenced by daily total protein intake but failed to vary by diabetes status. 
Although this association seemed relevant, the study inferred that the plausibil-
ity of accepting the utilization of urine osmolality adjustment and water intake 
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prescription to enhance on the accuracy of spot urine samples provision for the 
monitoring of bioenvironmental pollution would in itself espouse the merit for 
further evaluations [12].
4.1.4 Concentrated urine associated with BMI in HIV patients
High urine creatinine has a high correlation with body mass index, r = 0.74, in 
this study. This is in conformity with the findings reported by Forbes et al. [21] with 
r = 0.99 and Baxmann et al. [22] with r = 0.74. These two studies differed in design 
as they were administered in a very general population, compared to the present 
index subpopulation of our study that was an HIV patient population. The mar-
ginally higher correlation seen within the Forbes et al. [21] study showed a rather 
higher correlation which could be adduced to urine creatinine evaluation in lean 
body mass, in subjects very likely to be underweight.
4.1.5  Inverse correlation between concentrated urine and CD4 cell count and HDL 
in HIV patients
In this study high urine creatinine has a high inverse correlation, r = −0.71, with 
CD4 cell count. A study has documented an association between low CD4 cells 
count and underweight in HIV subjects [23]. Perhaps, this might account for the 
high, albeit inverse, correlation between high urine creatinine and CD4 cell count 
noted in our study. We also observed in our study that high urine creatinine has a 
high but inverse correlation, r = −0.73, with serum high-density lipoprotein choles-
terol. There was dearth of studies that assessed the link between serum high-density 
lipoprotein cholesterol and high urine creatinine.
4.1.6  Correlation between concentrated urine and 24-hour urine volume and 
anemia in HIV patients
This study showed that there was moderate correlation statistics between 
high urine creatinine and 24-hour urine volume (r = 0.58) and hemoglobin 
(r = −0.43). The higher the concentration of urine, the lower the hemoglobin, 
implying that anemia was associated with concentrated urine. Literature search 
did not reveal any study that evaluated the effects of urine volume or hemoglobin 
on urine creatinine.
4.2 Discussion in non-HIV patients
4.2.1 Absent abnormal urine concentration in non-HIV subjects
This study showed that low and high urine creatinine was absent within the 
outpatient population as all of them have 24-hour urine protein within the normal 
range.
4.2.2  Correlates of spot urine and daily urine creatinine excretion in non-HIV 
subjects
Spot urine creatinine correlated significantly with body mass index 
(r = 0.225, p = 0.009), spot urine protein (r = 0.292, p = 0.001), spot urine 
osmolality (r = 0.223, p = 0.009), 24-hour urine protein (r = −0.187, p = 0.030), 
24-hour urine creatinine (r = −0.178, p = 0.038), serum creatinine (r = −0.212, 
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p = 0.013), serum cholesterol (r = 0.246, p = 0.004), and serum low-density 
lipoprotein cholesterol (r = 0.282, p = 0.001). Factors that significantly cor-
related with 24-hour urine creatinine were 24-hour urine volume (r = 0.213, 
p = 0.013), serum creatinine (r = 0.741, p < 0.001), and spot urine creatinine 
(r = −0.178, p < 0.001). Spot urine protein and 24-hour urine protein predicted 
spot urine creatinine, whereas only serum creatinine predicted 24-hour urine 
creatinine.
4.2.3 Only normal levels of urine creatinine in non-HIV subjects
In this study there was an absence of low and high urine creatinine in subjects 
attending the outpatient clinic. This disagrees with the prevalence of 8.1% of low 
urine creatinine and 3.1% of high urine creatinine reported by Barr et al. [14]. Their 
study was conducted in a US general population in contrast with ours that was 
done in a general outpatient clinic population in Nigeria. This difference in study 
design might have accounted for the observed differences between the two studies. 
Additionally, our study subjects were patients who might have presented to hospital 
for one illness or the other that might impact on urine creatinine.
4.2.4 Spot urine creatinine associated with BMI in non-HIV subjects
Our study showed that BMI was associated with spot urine creatinine but not 
with 24-hour urine creatinine. This observation is similar to that reported in two 
studies [14, 24]. Two studies further demonstrated that body mass index was a 
predictor of spot urine creatinine [24, 25], in contrast with our study which showed 
that body mass index did not predict spot urine creatinine and 24-hour urine 
creatinine. Urine creatinine, a function of body mass index, a measure of lean body 
mass, depends on muscle mass.
4.2.5  Spot urine and daily urine protein excretion were predictors of spot urine 
creatinine in non-HIV subjects
This study demonstrated that spot urine protein and 24-hour urine protein 
were predictors of spot urine creatinine. This was slightly similar to a study that 
found protein intake associated with urine creatinine [26]. We observed that 
these two variables were not associated with 24-hour urine creatinine. Protein in 
urine predicting spot urine creatinine, with 24-hour urine creatinine within the 
normal range, indicated that the subjects studied might have proteinuria even in 
the presence of normal renal filtration function.
Spot urine osmolality was associated with spot urine creatinine but did not 
predict it, in this study. The precise relationship between urine creatinine and urine 
osmolality has not been fully elucidated, even though the utility of the hypotheti-
cal ratios for estimation of daily urine protein excretion involving creatinine and 
osmolality has been established [27, 28].
4.2.6  Inverse correlation between spot urine creatinine and daily urine creatinine 
excretion in non-HIV subjects
There was an inverse correlation between spot urine creatinine and 24-hour 
urine creatinine observed in this study. This implied that as spot urine creatinine 
increased, 24-hour urine creatinine declined and vice versa. Studies were sparse 
on the link between spot urine creatinine and 24-hour urine creatinine.
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4.2.7  Association between serum creatinine and spot urine creatinine in non-HIV 
subjects
The study showed that serum creatinine was associated with spot urine cre-
atinine. Serum creatinine in normal state is maintained at a reasonably constant 
level as excess creatinine produced by the body or taken exogenously is excreted 
in urine. This produces variability in the amount of creatinine in urine excreted 
by an individual and between different individuals [29]. However, elevated serum 
creatinine would be observed in impaired renal function, associated with reduced 
urine creatinine [30]. Expectedly, serum creatinine was a predictor of 24-hour urine 
creatinine in this study.
4.2.8 Spot urine creatinine associated with HDL and LDL in non-HIV subjects
Serum cholesterol and serum low-density lipoprotein cholesterol were associ-
ated with spot urine creatinine, as observed in our study. Lipid abnormalities have 
been described in renal disease associated with reduced urine creatinine excretion 
[31, 32]. This might suggest that our study subjects might have renal impairment.
4.2.9  Daily urine creatinine excretion associated with daily urine volume in  
non-HIV subjects
We noted that 24-hour urine volume was associated with 24-hour urine creati-
nine in this study. A related study reported an association between 24-hour urine 
volume and creatinine clearance [33]. In contrast, our study did not find any asso-
ciation between 24-hour urine creatinine and creatinine clearance. Nonetheless, 
urine volume tends to decrease with decreasing creatinine clearance, and 24-hour 
urine creatinine is a function of creatinine clearance. This probably would explain 
the association between 24-hour urine volume and 24-hour urine creatinine 
observed in this study.
5. Conclusion
The prevalence of low urine creatinine and high urine creatinine was low. 
Twenty-four-hour urine osmolality, body mass index, CD4 cell count, and hemo-
globin were strong correlates of high urine creatinine. Dyslipidemia was common 
in HIV subjects who have high urine creatinine. Low and high urine creatinine was 
absent in non-HIV subjects. Proteinuric renal abnormalities, abnormal weight, and 
dyslipidemia were common in these non-HIV subjects with normal urine creati-
nine. There is need for clinicians to routinely conduct urine creatinine and further 
search for dyslipidemia, abnormal weight, depressed immunity, and anemia in HIV 
subjects with dilute or concentrated urine in the early stages of the infection. There 
is also a necessity for clinicians to routinely conduct urine creatinine and further 
explore for abnormalities of lipids, renal function, and weight changes in subjects 
with normal urine creatinine in non-HIV subjects.
6. Limitations of the study in HIV subpopulation
A larger HIV study population would have been better, as it would have pre-
vented skewing of the colinearity that rendered null and void the multivariate linear 
regression of urine creatinine with the variables. Staging of HIV infection for all the 
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subjects and concisely defining the time from the diagnosis of HIV infection in these 
subjects to the conduct of this study were not done but would have contributed in 
further defining the link between urine creatinine and these factors. Similarly, the 
non-HIV study population was small. A way larger sample size would have shown a 
proportion of these with low and high urine creatinine, however little they may be, 
and also the potential risk factors of dilute and concentrated urine in this population.
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